BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 20495877)

  • 1. Magnetic resonance colonography for colorectal cancer screening in patients with Lynch syndrome gene mutation.
    Lim EJ; Leung C; Pitman A; Stella DL; Brown G; Slattery M; Marion K; Macrae F
    Fam Cancer; 2010 Dec; 9(4):555-61. PubMed ID: 20495877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromoendoscopic colonoscopy for detecting preneoplastic lesions in hereditary nonpolyposis colorectal cancer syndrome.
    Lecomte T; Cellier C; Meatchi T; Barbier JP; Cugnenc PH; Jian R; Laurent-Puig P; Landi B
    Clin Gastroenterol Hepatol; 2005 Sep; 3(9):897-902. PubMed ID: 16234028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ten years after mutation testing for Lynch syndrome: cancer incidence and outcome in mutation-positive and mutation-negative family members.
    Järvinen HJ; Renkonen-Sinisalo L; Aktán-Collán K; Peltomäki P; Aaltonen LA; Mecklin JP
    J Clin Oncol; 2009 Oct; 27(28):4793-7. PubMed ID: 19720893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of colorectal cancer by colonoscopic surveillance in families with hereditary colorectal cancer.
    Stormorken AT; Clark N; Grindedal E; Maehle L; Møller P
    Scand J Gastroenterol; 2007 May; 42(5):611-7. PubMed ID: 17454882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations of Pathogenic Variants in MLH1, MSH2, and MSH6 With Risk of Colorectal Adenomas and Tumors and With Somatic Mutations in Patients With Lynch Syndrome.
    Engel C; Ahadova A; Seppälä TT; Aretz S; Bigirwamungu-Bargeman M; Bläker H; Bucksch K; Büttner R; de Vos Tot Nederveen Cappel WT; Endris V; Holinski-Feder E; Holzapfel S; Hüneburg R; Jacobs MAJM; Koornstra JJ; Langers AM; Lepistö A; Morak M; Möslein G; Peltomäki P; Pylvänäinen K; Rahner N; Renkonen-Sinisalo L; Schulmann K; Steinke-Lange V; Stenzinger A; Strassburg CP; van de Meeberg PC; van Kouwen M; van Leerdam M; Vangala DB; Vecht J; Verhulst ML; von Knebel Doeberitz M; Weitz J; Zachariae S; Loeffler M; Mecklin JP; Kloor M; Vasen HF; ;
    Gastroenterology; 2020 Apr; 158(5):1326-1333. PubMed ID: 31926173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of families with Lynch syndrome complicated by advanced serrated neoplasia: the importance of pathology review and pedigree analysis.
    Walsh MD; Buchanan DD; Walters R; Roberts A; Arnold S; McKeone D; Clendenning M; Ruszkiewicz AR; Jenkins MA; Hopper JL; Goldblatt J; George J; Suthers GK; Phillips K; Young GP; Macrae F; Drini M; Woods MO; Parry S; Jass JR; Young JP
    Fam Cancer; 2009; 8(4):313-23. PubMed ID: 19241144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Yield of routine molecular analyses in colorectal cancer patients ≤70 years to detect underlying Lynch syndrome.
    van Lier MG; Leenen CH; Wagner A; Ramsoekh D; Dubbink HJ; van den Ouweland AM; Westenend PJ; de Graaf EJ; Wolters LM; Vrijland WW; Kuipers EJ; van Leerdam ME; Steyerberg EW; Dinjens WN;
    J Pathol; 2012 Apr; 226(5):764-74. PubMed ID: 22081473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term risk of colorectal cancer in individuals with lynch syndrome: a meta-analysis.
    Jenkins MA; Dowty JG; Ait Ouakrim D; Mathews JD; Hopper JL; Drouet Y; Lasset C; Bonadona V; Win AK
    J Clin Oncol; 2015 Feb; 33(4):326-31. PubMed ID: 25534380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In Lynch syndrome adenomas, loss of mismatch repair proteins is related to an enhanced lymphocytic response.
    Meijer TW; Hoogerbrugge N; Nagengast FM; Ligtenberg MJ; van Krieken JH
    Histopathology; 2009 Oct; 55(4):414-22. PubMed ID: 19817892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation and management of Lynch syndrome.
    Boland CR
    Clin Adv Hematol Oncol; 2007 Nov; 5(11):851,873. PubMed ID: 18185481
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevalence of adenomas and hyperplastic polyps in mismatch repair mutation carriers among CAPP2 participants: report by the colorectal adenoma/carcinoma prevention programme 2.
    Liljegren A; Barker G; Elliott F; Bertario L; Bisgaard ML; Eccles D; Evans G; Macrae F; Maher E; Lindblom A; Rotstein S; Nilsson B; Mecklin JP; Möslein G; Jass J; Fodde R; Mathers J; Burn J; Bishop DT
    J Clin Oncol; 2008 Jul; 26(20):3434-9. PubMed ID: 18612159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Missed adenomas during colonoscopic surveillance in individuals with Lynch Syndrome (hereditary nonpolyposis colorectal cancer).
    Stoffel EM; Turgeon DK; Stockwell DH; Zhao L; Normolle DP; Tuck MK; Bresalier RS; Marcon NE; Baron JA; Ruffin MT; Brenner DE; Syngal S;
    Cancer Prev Res (Phila); 2008 Nov; 1(6):470-5. PubMed ID: 19138994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colonoscopy use following mutation detection in Lynch syndrome: exploring a role for cancer screening in adaptation.
    Hadley DW; Ashida S; Jenkins JF; Calzone KA; Kirsch IR; Koehly LM
    Clin Genet; 2011 Apr; 79(4):321-8. PubMed ID: 21204803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of computed tomographic colonography in surveillance for hereditary nonpolyposis colorectal cancer syndrome.
    Renkonen-Sinisalo L; Kivisaari A; Kivisaari L; Sarna S; Järvinen HJ
    Fam Cancer; 2007; 6(1):135-40. PubMed ID: 17273816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival Outcome and Risk of Metachronous Colorectal Cancer After Surgery in Lynch Syndrome.
    Kim TJ; Kim ER; Hong SN; Kim YH; Huh JW; Park YA; Cho YB; Yun SH; Kim HC; Lee WY; Kim K; Kim K; Chang DK
    Ann Surg Oncol; 2017 Apr; 24(4):1085-1092. PubMed ID: 27766559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of mismatch repair-deficient crypt foci in Lynch syndrome: a pathological study.
    Kloor M; Huth C; Voigt AY; Benner A; Schirmacher P; von Knebel Doeberitz M; Bläker H
    Lancet Oncol; 2012 Jun; 13(6):598-606. PubMed ID: 22552011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance of computed tomographic colonography for the screening of colorectal polyp in acromegalic patients: a prospective study.
    Ramos O; Boguszewski CL; Teixeira S; De Bem R; Parolim B; Prolla JC
    Arq Gastroenterol; 2009; 46(2):90-6. PubMed ID: 19578607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One to 2-year surveillance intervals reduce risk of colorectal cancer in families with Lynch syndrome.
    Vasen HF; Abdirahman M; Brohet R; Langers AM; Kleibeuker JH; van Kouwen M; Koornstra JJ; Boot H; Cats A; Dekker E; Sanduleanu S; Poley JW; Hardwick JC; de Vos Tot Nederveen Cappel WH; van der Meulen-de Jong AE; Tan TG; Jacobs MA; Mohamed FL; de Boer SY; van de Meeberg PC; Verhulst ML; Salemans JM; van Bentem N; Westerveld BD; Vecht J; Nagengast FM
    Gastroenterology; 2010 Jun; 138(7):2300-6. PubMed ID: 20206180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obesity, Aspirin, and Risk of Colorectal Cancer in Carriers of Hereditary Colorectal Cancer: A Prospective Investigation in the CAPP2 Study.
    Movahedi M; Bishop DT; Macrae F; Mecklin JP; Moeslein G; Olschwang S; Eccles D; Evans DG; Maher ER; Bertario L; Bisgaard ML; Dunlop MG; Ho JW; Hodgson SV; Lindblom A; Lubinski J; Morrison PJ; Murday V; Ramesar RS; Side L; Scott RJ; Thomas HJ; Vasen HF; Burn J; Mathers JC
    J Clin Oncol; 2015 Nov; 33(31):3591-7. PubMed ID: 26282643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Taiwan hospital-based detection of Lynch syndrome distinguishes 2 types of microsatellite instabilities in colorectal cancers.
    Chang SC; Lin PC; Yang SH; Wang HS; Liang WY; Lin JK
    Surgery; 2010 May; 147(5):720-8. PubMed ID: 20045164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.